You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neurokinin Receptor

Showing 1 - 25 of 7,167
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Gynecologic Cancer Trial in Ann Arbor (Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA))

Recruiting
  • Gynecologic Cancer
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 6, 2022

Prurigo Nodularis Trial in Germany (serlopitant, Placebo)

Completed
Has Results
  • Prurigo Nodularis
  • Berlin-Mitte, Germany
  • +14 more
May 18, 2021

Menopausal Flushing Trial in London (NK3R antagonist - AZD4901, Placebo)

Completed
Has Results
  • Menopausal Flushing
  • NK3R antagonist - AZD4901
  • Placebo
  • London, United Kingdom
    NIHR/Wellcome Trust Imperial CRF
Apr 7, 2021

Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus Trial in Lahore (NK-1R antagonist)

Unknown status
  • Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
  • NK-1R antagonist
  • Lahore, Punjab, Pakistan
    Bahria International Hospital
Jul 10, 2020

Epidermolysis Bullosa, Pruritus Trial in Stanford (VPD-737, Placebo)

Completed
Has Results
  • Epidermolysis Bullosa
  • Pruritus
  • Stanford, California
    Stanford
Mar 10, 2020

C.Surgical Procedure; Gastrointestinal Trial in Guangzhou (palonosteron, dexamethasone, and fosaprepitant dissolved in 0.9%

Completed
  • C.Surgical Procedure; Gastrointestinal
  • palonosetron, dexamethasone, and fosaprepitant dissolved in 0.9% NaCl
  • palonosetron, dexamethasone, and 0.9% NaCl
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Dec 26, 2022

Chemo Induced Nausea and Vomiting Trial in Mount Olive (Akynzeo)

Recruiting
  • Chemotherapy Induced Nausea and Vomiting
  • Mount Olive, Alabama
    Rudolph M Navari
Oct 8, 2023

Functional Dyspepsia Trial in Rochester (Tradipitant, Placebo)

Not yet recruiting
  • Functional Dyspepsia
  • Rochester, Minnesota
    Vanda Investigational Site
Dec 7, 2022

Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)

Not yet recruiting
  • Nausea With Vomiting Chemotherapy-Induced
  • Ondansetron every 3 weeks
  • +3 more
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Oct 8, 2023

Hyperactivity, Allergic Rhinitis Due to House Dust Mite, Chronic Rhinosinusitis With Nasal Polyps Trial in Leuven (Cold, dry

Active, not recruiting
  • Hyperactivity
  • +2 more
  • Cold, dry air
  • Leuven, Belgium
    KULeuven
May 24, 2022

Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy Trial in Tanta (Ondansetron 4mg + dexmedetomidine 0.5 ug/kg +

Recruiting
  • Postoperative Nausea and Vomiting
  • Laparoscopic Cholecystectomy
  • Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .
  • Ondansetron 4mg + dexamethasone 8mg + normal saline.
  • Tanta, Algharbia, Egypt
    Tanta University hospitals
Aug 26, 2023

Chemo-induced Nausea and Vomiting, Adverse Event, Cervical Cancer Trial in Odense (Akynzeo, Dexamethasone)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • +2 more
  • Odense, Denmark
    Department of Oncology, Odense University Hospital
Dec 12, 2021

Following Menopause Treated WithNon-hormonal Therapy for Hot

Not yet recruiting
  • Hot Flashes
  • (no location specified)
Sep 18, 2023

Postoperative Nausea and Vomiting, Anesthesia Complication, Thoracic Diseases Trial (Ondansetron 8mg, Fosaprepitant 150 mg)

Not yet recruiting
  • Postoperative Nausea and Vomiting
  • +2 more
  • Ondansetron 8mg
  • Fosaprepitant 150 mg
  • (no location specified)
Jun 4, 2023

Chemo-induced Nausea and Vomiting, Lung Cancer Trial in Zunyi, Nanchong (Olanzapine, Placebos)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Lung Cancer
  • Zunyi, Guizhou, China
  • +1 more
Jul 12, 2021

Chemo-induced Nausea and Vomiting (CINV) Trial (Granisetron transdermal patch, Palonosetron, Aprepitant)

Not yet recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron transdermal patch
  • +4 more
  • (no location specified)
Jun 2, 2021

Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron Transdermal Delivery System
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 19, 2022

Head Neck Cancer Trial in Berlin (SPRANC Block group, SPRANC Control group)

Suspended
  • Head and Neck Cancer
  • SPRANC Block group
  • SPRANC Control group
  • Berlin, Germany
    Charité Universitaetsmedizin Berlin
Jan 21, 2022

Breast Cancer Trial (use of a smartphone app for adverse event management, conventional adverse event management)

Not yet recruiting
  • Breast Cancer
  • use of a smartphone app for adverse event management
  • conventional adverse event management
  • (no location specified)
Feb 16, 2022

Olanzapine, CINV, Testicular Cancer by AJCC V6 and V7 Stage Trial in Guangzhou (Olanzapine Tablets, Placebo)

Recruiting
  • Olanzapine
  • +3 more
  • Olanzapine Tablets
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Feb 14, 2022

Chemo-induced Nausea and Vomiting Trial in Chapel Hill (Olanzapine 5 MG, Placebo)

Completed
  • Chemotherapy-induced Nausea and Vomiting
  • Olanzapine 5 MG
  • Placebo
  • Chapel Hill, North Carolina
    UNC Hospital
Nov 28, 2022

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Labor Pain, Pregnancy Loss, Labor Induction Trial (capsaicin, Placebo)

Withdrawn
  • Labor Pain
  • +2 more
  • (no location specified)
Aug 3, 2021

Cancer Trial in Xining (True acupuncture + standard antiemetic treatment, Sham acupuncture + standard antiemetic treatment)

Recruiting
  • Cancer
  • True acupuncture + standard antiemetic treatment
  • Sham acupuncture + standard antiemetic treatment
  • Xining, Qinghai, China
    Jiuda Zhao
Mar 22, 2022